1[1]Gottsater A, Landin-Olsson M, Fernlund P, et al. β-cell function in relation to islet cell antibodies(ICA)during the first three years after the clinical diagnosis of diabetes in non-insulin-dependent (typeⅡ)diabetes patients.Diabetes Care,1993,16:902-905.
3Alberti KG,Zimmet PZ.For the WHO consultation:Definition,diagnosis and classification of diabetes mellitus and its complications.Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.Diabet Med,1998,15:539-553.
4Kobayashi T,Maruyama T,Shinada A,et al.Insuliu.Intervention to preserve βCells in slowly progressive insulin-dependent(type 1) diabetes mellitus.Ann NY Aead Sci,2002,958:117-130.
5向红丁.磺脲类口服降糖药继发失效[J].辽宁实用糖尿病杂志,1993,1:16-18.
6Boden G.Role of fatty acids in the pathogenesis of insulin resistance and NIDDM[J].Diabete,1997,46:3-8.
7Robertson RP,Olson LK,Zhang HJ.Differentiating glucose toxicity from glucose desensitization:a new message from the insulin gene[J].Diabetes,1994,43:1085-1089.
8Cenuth S.Management of the adult onset diabetic with sulfonylurea drug failure[J].Endocrinol Metab Clin North Am,1992,21:351-370.
